Belen Ramos

Dr. Belen Ramos

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BRBelen Ramos
Belen Ramos
BGBrice Gaudillière
Brice Gaudillière
ABAzad Bonni
Azad Bonni
GGGrace Gill
Grace Gill
Integration of inputs by a neuron depends on dendritic arborization patterns. In mammals, the genetic programs that regulate dynamic remodeling of dendrites during development and in response to activity are incompletely understood. Here we report that knockdown of the transcription factor Sp4 led to an increased number of highly branched dendrites during maturation of cerebellar granule neurons in dissociated cultures and in cerebellar cortex. Time-course analysis revealed that depletion of Sp4 led to persistent generation of dendritic branches and a failure in resorption of transient dendrites. Depolarization induced a reduction in the number of dendrites, and knockdown of Sp4 blocked depolarization-induced remodeling. Furthermore, overexpression of Sp4 wild type, but not a mutant lacking the DNA-binding domain, was sufficient to promote dendritic pruning in nondepolarizing conditions. These findings indicate that the transcription factor Sp4 controls dendritic patterning during cerebellar development by limiting branch formation and promoting activity-dependent pruning.

1 January 2015 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
BABelén Ansoleaga
Belén Ansoleaga
PGPaula Garcia-Esparcia
Paula Garcia-Esparcia
RPRaquel Pinacho
Raquel Pinacho
JHJosep Maria Haro
Josep Maria Haro
BRBelen Ramos
Belen Ramos
Isidro FerrerIsidro Ferrer
Isidro Ferrer

17 September 2003 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
RPRaúl Pardo
Raúl Pardo
AAAlberto G. Andreolotti
Alberto G. Andreolotti
BRBelen Ramos
Belen Ramos
FPFernando Picatoste
Fernando Picatoste
ECEnrique Claro
Enrique Claro
Summary: Lithium is widely used in the treatment of bipolar disorder, but despite its proven therapeutic efficacy, the molecular mechanisms of action are not fully understood. The present study was undertaken to explore lithium effects of the MEK/ERK cascade of protein kinases in astrocytes and neurons. In asynchronously proliferating rat cortical astrocytes, lithium decreased time‐ and dose‐dependently the phosphorylation of MEK and ERK, with 1 mm concentrations achieving 60 and 50% inhibition of ERK and MEK, respectively, after a 7‐day exposure. Lithium also inhibited [3H]thymidine incorporation into DNA and induced a G2/M cell cycle arrest. In serum‐deprived, quiescent astrocytes, pre‐exposure to lithium resulted in the inhibition of cell cycle re‐entry as stimulated by the mitogen endothelin‐1: under this experimental setting, lithium did not affect the rapid, peak phosphorylation of MEK taking place after 3–5 min, but was effective in inhibiting the long‐term, sustained phosphorylation of MEK. Lithium inhibition of the astrocyte MEK/ERK pathway was independent of inositol depletion. Further, compound SB216763 inhibited Tau phosphorylation at Ser396 and stabilized cytosolic β‐catenin, consistent with the inhibition of glycogen synthase kinase‐3β (GSK‐3β), but failed to reproduce lithium effects on MEK and ERK phosphorylation and cell cycle arrest. In cerebellar granule neurons, millimolar concentrations of lithium enhanced MEK and ERK phosphorylation in a concentration‐dependent manner, again through an inositol and GSK‐3β independent mechanism. These opposing effects in astrocytes and neurons make lithium treatment a promising strategy to favour neural repair and reduce reactive gliosis after traumatic injury.

1 August 2011 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
RPRaquel Pinacho
Raquel Pinacho
NVNuria Villalmanzo
Nuria Villalmanzo
JLJasmin Lalonde
Jasmin Lalonde
JHJosep Maria Haro
Josep Maria Haro
JMJ Javier Meana
J Javier Meana
BRBelen Ramos
Belen Ramos

1 July 2013 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
RPRaquel Pinacho
Raquel Pinacho
NVNúria Villalmanzo
Núria Villalmanzo
MRMercedes Roca
Mercedes Roca
RIRaquel Iniesta
Raquel Iniesta
AMAlfonso Monje
Alfonso Monje
BRBelen Ramos
Belen Ramos

1 March 2019 in European Neuropsychopharmacology
Verified
Journal Article
Open access
ILIrene López-González
Irene López-González
RPRaquel Pinacho
Raquel Pinacho
ÈVÈlia Vila
Èlia Vila
AEAna Escanilla
Ana Escanilla
Isidro FerrerIsidro Ferrer
Isidro Ferrer
BRBelen Ramos
Belen Ramos
Cognitive deterioration and symptom progression occur in schizophrenia over the course of the disorder. A dysfunction of the immune system/neuroinflammatory pathways has been linked to schizophrenia (SZ). These altered processes in the dorsolateral prefrontal cortex (DLPFC) could contribute to the worsening of the deficits. However, limited studies are available in this brain region in elderly population with long-term treatments. In this study, we explore the possible deregulation of 21 key genes involved in immune homeostasis, including pro- and anti-inflammatory cytokines, cytokine modulators (toll-like receptors, colony-stimulating factors, and members of the complement system) and microglial and astroglial markers in the DLPFC in elderly chronic schizophrenia. We used quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) on extracts from postmortem DLPFC of elderly subjects with chronic SZ (n = 14) compared to healthy control individuals (n = 14). We report that CSF1R, TLR4, IL6, TNFα, TNFRSF1A, IL10, IL10RA, IL10RB, and CD68 were down-regulated in elderly SZ subjects. Moreover, we found that the expression levels of all the altered inflammatory genes in SZ correlated with the microglial marker CD68. However, no associations were found with the astroglial marker GFAP. This study reveals a decrease in the gene expression of cytokines and immune response/inflammation mediators in the DLPFC of elderly subjects with chronic schizophrenia, supporting the idea of a dysfunction of these processes in aged patients and its possible relationship with active microglia abundance. These findings include elements that might contribute to the cognitive decline and symptom progression linked to DLPFC functioning at advanced stages of the disease.